Results 141 to 150 of about 2,746 (190)
Tolerability and Shared Decision-Making in the Hormonal Management of Endometriosis-Associated Pain. [PDF]
BiomedicinesPinto da Costa Viana D +6 more
europepmc +1 more source
Impact of endometrioma management strategies on ovarian reserve over the follow-up period, a prospective longitudinal study. [PDF]
Front Endocrinol (Lausanne)Aslan K +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Drugs, 1998
The progestogen dienogest exhibits highly selective binding to the progesterone receptor. It has high progestational and significant antiandrogenic activity, but only moderate antigonadotrophic activity. Dienogest inhibits ovulation, produces secretory transformation of the endometrium and has antiproliferative effects.
R H, Foster, M I, Wilde
+5 more sources
The progestogen dienogest exhibits highly selective binding to the progesterone receptor. It has high progestational and significant antiandrogenic activity, but only moderate antigonadotrophic activity. Dienogest inhibits ovulation, produces secretory transformation of the endometrium and has antiproliferative effects.
R H, Foster, M I, Wilde
+5 more sources
Fertility and Sterility, 2016 OBJECTIVE: To assess the proportion of patients satisfied with their treatment before and after a systematic change from norethindrone acetate to dienogest as the first-line progestin for symptomatic endometriosis.
Edgardo Somigliana +2 more
exaly +2 more sources
Effect of Dienogest therapy on the size of the endometrioma
Gynecological Endocrinology, 2020 Studies have been published on the efficacy of Dienogest in the management of pain symptoms in endometriosis. Nonetheless, few data are available on the reducing effect on endometrioma’s size.
Stefano Angioni +2 more
exaly +2 more sources
Maturitas, 2012
Dienogest (DNG) is a 19-nortestosterone derivative (a C-19 progestogen) with a cyanomethyl instead of an ethinyl group at the C-17 position, which may make the compound elicit fewer hepatic effects than other C-19 nortestosterone derivatives. Its similarity to norethisterone is reflected in its high endometrial efficacy, which could explain the high ...
Xiangyan, Ruan, H, Seeger, A O, Mueck
openaire +3 more sources
Dienogest (DNG) is a 19-nortestosterone derivative (a C-19 progestogen) with a cyanomethyl instead of an ethinyl group at the C-17 position, which may make the compound elicit fewer hepatic effects than other C-19 nortestosterone derivatives. Its similarity to norethisterone is reflected in its high endometrial efficacy, which could explain the high ...
Xiangyan, Ruan, H, Seeger, A O, Mueck
openaire +3 more sources
Drugs, 2002
Estradiol valerate 2mg/dienogest 2mg is an oral estrogen/ progestogen formulation that has been approved throughout the European Union for the treatment of climacteric symptoms in postmenopausal women. Dienogest is a progestogen that combines the properties of both progesterone and 19-nortestosterone derivatives.
Keri, Wellington, Caroline M, Perry
openaire +2 more sources
Estradiol valerate 2mg/dienogest 2mg is an oral estrogen/ progestogen formulation that has been approved throughout the European Union for the treatment of climacteric symptoms in postmenopausal women. Dienogest is a progestogen that combines the properties of both progesterone and 19-nortestosterone derivatives.
Keri, Wellington, Caroline M, Perry
openaire +2 more sources